135 related articles for article (PubMed ID: 32526010)
1. IL-23R in laryngeal cancer: a cancer immunoediting process that facilitates tumor cell proliferation and results in cisplatin resistance.
Tao Y; Shen H; Liu Y; Li G; Huang Z; Liu Y
Carcinogenesis; 2021 Feb; 42(1):118-126. PubMed ID: 32526010
[TBL] [Abstract][Full Text] [Related]
2. Combined Effect of IL-12Rβ2 and IL-23R Expression on Prognosis of Patients with Laryngeal Cancer.
Tao Y; Tao T; Gross N; Peng X; Li Y; Huang Z; Liu L; Li G; Chen X; Yang J
Cell Physiol Biochem; 2018; 50(3):1041-1054. PubMed ID: 30355949
[TBL] [Abstract][Full Text] [Related]
3. A high ratio of IL-12Rβ2-positive tumor-infiltrating lymphocytes indicates favorable prognosis in laryngeal cancer.
Tao Y; Gross N; Liu Y; Zhang L; Li G; Huang Z; Yang J
Oral Oncol; 2017 Nov; 74():148-156. PubMed ID: 29103744
[TBL] [Abstract][Full Text] [Related]
4. Identification of canonical tyrosine-dependent and non-canonical tyrosine-independent STAT3 activation sites in the intracellular domain of the interleukin 23 receptor.
Floss DM; Mrotzek S; Klöcker T; Schröder J; Grötzinger J; Rose-John S; Scheller J
J Biol Chem; 2013 Jul; 288(27):19386-400. PubMed ID: 23673666
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-23 promotes the migration and invasion of gastric cancer cells by inducing epithelial-to-mesenchymal transition via the STAT3 pathway.
Xu X; Yang C; Chen J; Liu J; Li P; Shi Y; Yu P
Biochem Biophys Res Commun; 2018 May; 499(2):273-278. PubMed ID: 29574157
[TBL] [Abstract][Full Text] [Related]
6. Human interleukin 23 receptor induces cell apoptosis in mammalian cells by intrinsic mitochondrial pathway associated with the down-regulation of RAS/mitogen-activated protein kinase and signal transducers and activators of transcription factor 3 signaling pathways.
Shi WY; Che CY; Liu L
Int J Mol Sci; 2013 Dec; 14(12):24656-69. PubMed ID: 24351840
[TBL] [Abstract][Full Text] [Related]
7. LncRNA SNHG1 promotes cell proliferation in laryngeal cancer via Notch1 signaling pathway.
Liu T; Zuo JJ; Li F; Xu YC; Zheng AY; Tao ZZ
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6562-6569. PubMed ID: 31378897
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma.
Vassilakopoulou M; Avgeris M; Velcheti V; Kotoula V; Rampias T; Chatzopoulos K; Perisanidis C; Kontos CK; Giotakis AI; Scorilas A; Rimm D; Sasaki C; Fountzilas G; Psyrri A
Clin Cancer Res; 2016 Feb; 22(3):704-13. PubMed ID: 26408403
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 23 regulates proliferation of lung cancer cells in a concentration-dependent way in association with the interleukin-23 receptor.
Li J; Zhang L; Zhang J; Wei Y; Li K; Huang L; Zhang S; Gao B; Wang X; Lin P
Carcinogenesis; 2013 Mar; 34(3):658-66. PubMed ID: 23250909
[TBL] [Abstract][Full Text] [Related]
10. IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells.
Zhu X; Shen H; Yin X; Long L; Chen X; Feng F; Liu Y; Zhao P; Xu Y; Li M; Xu W; Li Y
Oncotarget; 2017 Jun; 8(24):39154-39166. PubMed ID: 28388577
[TBL] [Abstract][Full Text] [Related]
11. Proportion of CD4 and CD8 tumor infiltrating lymphocytes predicts survival in persistent/recurrent laryngeal squamous cell carcinoma.
Hoesli R; Birkeland AC; Rosko AJ; Issa M; Chow KL; Michmerhuizen NL; Mann JE; Chinn SB; Shuman AG; Prince ME; Wolf GT; Bradford CR; McHugh JB; Brenner JC; Spector ME
Oral Oncol; 2018 Feb; 77():83-89. PubMed ID: 29362129
[TBL] [Abstract][Full Text] [Related]
12. Tumor angiogenesis as a predictive marker for organ preservation in patients with advanced laryngeal carcinoma.
Teknos TN; Cox C; Barrios MA; Chepeha DB; Bradford CR; Fisher SG; Wolf GT
Laryngoscope; 2002 May; 112(5):844-51. PubMed ID: 12150616
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway.
Tao L; Huang G; Wang R; Pan Y; He Z; Chu X; Song H; Chen L
Sci Rep; 2016 Dec; 6():38408. PubMed ID: 27922075
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of IL-23/IL-23R in patients with breast cancer and its clinical significance.
Sheng S; Zhang J; Ai J; Hao X; Luan R
Mol Med Rep; 2018 Mar; 17(3):4639-4644. PubMed ID: 29328397
[TBL] [Abstract][Full Text] [Related]
15. Supraglottic laryngeal tumor microenvironmental factors facilitate STAT3 dependent pro-tumorigenic switch in tumor associated macrophages to render utmost immune evasion.
Goswami KK; Barik S; Banerjee S; Bhowmick AK; Biswas J; Bose A; Baral R
Immunol Lett; 2013; 156(1-2):7-17. PubMed ID: 24029664
[TBL] [Abstract][Full Text] [Related]
16. Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer.
Patel SA; Qureshi MM; Dyer MA; Jalisi S; Grillone G; Truong MT
Cancer; 2019 Oct; 125(19):3367-3377. PubMed ID: 31206637
[TBL] [Abstract][Full Text] [Related]
17. Th22 cell accumulation is associated with colorectal cancer development.
Huang YH; Cao YF; Jiang ZY; Zhang S; Gao F
World J Gastroenterol; 2015 Apr; 21(14):4216-24. PubMed ID: 25892871
[TBL] [Abstract][Full Text] [Related]
18. Impact of EGFR immunoexpression on STAT3 activation and association with proinflammatory/regulatory cytokine pattern in laryngeal squamous cell carcinoma.
Starska K; Brys M; Forma E; Glowacka E; Lewy-Trenda I; Stasikowska O; Krajewska WM; Lukomski M
Oncol Rep; 2009 Feb; 21(2):539-48. PubMed ID: 19148533
[TBL] [Abstract][Full Text] [Related]
19. Specific targeting of the IL-23 receptor, using a novel small peptide noncompetitive antagonist, decreases the inflammatory response.
Quiniou C; Domínguez-Punaro M; Cloutier F; Erfani A; Ennaciri J; Sivanesan D; Sanchez M; Chognard G; Hou X; Rivera JC; Beauchamp C; Charron G; Vilquin M; Kuchroo V; Michnick S; Rioux JD; Lesage S; Chemtob S
Am J Physiol Regul Integr Comp Physiol; 2014 Nov; 307(10):R1216-30. PubMed ID: 25354400
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells.
Yin Z; Zhang Y; Li Y; Lv T; Liu J; Wang X
Acta Histochem; 2012 Feb; 114(2):151-8. PubMed ID: 21549414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
